Factors associated with parental reasons for \u201cno-intent\u201d to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008\u20132012

Madhav P. Bhatta,Lauren N. Drinkard,Vinay K. Cheruvu

doi:10.1186/s12887-017-0804-1

Madhav P. Bhatta, Lauren N. Drinkard + Show 1 more

Open Access

https://doi.org/10.1186/s12887-017-0804-1

Copy DOI

Journal: BMC Pediatrics	Publication Date: Feb 13, 2017
Citations: 29	License type: open-access

Affiliation: Kent State University

Abstract

Background1) To identify socio-demographic factors associated with parental “no-intent” for their 13–17 year old unvaccinated daughter to receive the human papillomavirus (HPV) vaccine series within the next twelve months, 2) to describe patterns in “no-intent” by socio-demographic factors, and 3) to identify socio-demographic factors associated with parental reasons for “no-intent”.MethodsData from 2008–2012 National Immunization Survey - Teen (NIS - Teen) were examined in this study. Parents with “no-intent” to vaccinate their daughters were asked to identify reasons for their decision. All responses were categorized into five domains identified as barriers to receive the HPV vaccine series: 1) Safety and Effectiveness Concerns; 2) Systemic Barriers; 3) Vaccine Misinformation; 4) Lack of Knowledge about the Vaccine; and 5) Socio-cultural Barriers. Multivariable logistic regression models were performed to address the study objectives.ResultsNumber of people in the household, household income, mother’s age, education, health insurance, recommendation of a health care provider, and the survey year were significantly associated with parental “no-intent”. Race/ethnicity, mother’s education, marital status, recommendation of a health care provider, household income, age of the unvaccinated daughter, and the survey year, were significantly associated with one or more domains identified as barriers to receive the HPV vaccine.ConclusionsThis study identified sub-groups of parents across different socio-demographic factors with “no-intent” for their adolescent daughters to receive the HPV vaccine. Developing strategies that target educational tools towards the identified sub-groups of parents about the purpose, safety, and efficacy of the HPV vaccine, and HPV infection, may help increase HPV vaccine acceptance, initiation and completion rates.

Highlights

1) To identify socio-demographic factors associated with parental “no-intent” for their 13–17 year old unvaccinated daughter to receive the human papillomavirus (HPV) vaccine series within the twelve months, 2) to describe patterns in “no-intent” by socio-demographic factors, and 3) to identify socio-demographic factors associated with parental reasons for “no-intent”
We used a sub-sample of unvaccinated females aged 13–17 years from the National Immunization Survey - Teen (NIS - Teen), 2008–2012, to address three specific objectives: 1) To identify socio-demographic factors associated with parental “no-intent” for their 13–17 year old unvaccinated daughter to receive the human papillomavirus (HPV) vaccine series in the twelve months, 2) to describe patterns in “no-intent” by sociodemographic factors, and 3) to identify socio-demographic factors associated with parental reasons for “no-intent”
Socio-demographic factors associated with no-intent to receive the HPV vaccine series During 2008–2012, 59.9% of parents of unvaccinated adolescent females indicated that they did not intend to have their daughters vaccinated against HPV within the 12 months

Summary

Introduction

1) To identify socio-demographic factors associated with parental “no-intent” for their 13–17 year old unvaccinated daughter to receive the human papillomavirus (HPV) vaccine series within the twelve months, 2) to describe patterns in “no-intent” by socio-demographic factors, and 3) to identify socio-demographic factors associated with parental reasons for “no-intent”. In the United States (U.S.), human papillomavirus (HPV) is the most prevalent sexually transmitted infection (STI) with up to 24.5% HPV infection among females aged 14–19 years [1,2,3]. HPV types 6 and 11, cause 90% of genital warts and HPV types 16 and 18, cause 70% of cervical cancers [4]. In 2014, the 9-valent (Gardasil 9) virus-like particle HPV vaccine was approved which has the potential to increase cervical cancer prevention from 70% to 90% [10, 11]. The Healthy People 2020 goal for HPV vaccine coverage among female adolescents aged 13–15 years in the U.S is 80% [12].

Methods

Results

Discussion

Conclusion